{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:56:22Z","timestamp":1781920582113,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.eprac.2022.12.004","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T23:44:09Z","timestamp":1670802249000},"page":"388-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association of Insulin-Like Growth Factor-1 With Polycystic Ovarian Syndrome: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"29","author":[{"given":"Huanhuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-4899","authenticated-orcid":false,"given":"Haihong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2022.12.004_bib1","article-title":"Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on menstrual cycle abnormalities, hormonal profile, and IGF-1 system in polycystic ovary syndrome patients: a randomized, placebo-controlled clinical trial","volume":"2019","author":"Kadoura","year":"2019","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.eprac.2022.12.004_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.004_bib3","first-page":"4889","article-title":"Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome","volume":"17","author":"Zhong","year":"2018","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.eprac.2022.12.004_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/jhrs.jhrs_104_22","article-title":"Correlation of markers of inflammation with hormonal, metabolic parameters, insulin resistance and adiposity indices in first-degree relatives of patient with polycystic ovary syndrome","volume":"15","author":"Pradhan","year":"2022","journal-title":"J\u00a0Hum Reprod Sci"},{"key":"10.1016\/j.eprac.2022.12.004_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820934319","article-title":"Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome","volume":"11","author":"Kempegowda","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1A","key":"10.1016\/j.eprac.2022.12.004_bib6","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1016\/S0002-9343(99)80059-X","article-title":"The insulin-like growth factor system in normal and abnormal human ovarian follicle development","volume":"98","author":"Giudice","year":"1995","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.eprac.2022.12.004_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cnur.2018.04.008","article-title":"Polycystic Ovary Syndrome","volume":"53","author":"Meier","year":"2018","journal-title":"Nurs Clin North Am"},{"key":"10.1016\/j.eprac.2022.12.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104588","article-title":"The influence of metformin on IGF-1 levels in humans: a systematic review and meta-analysis","volume":"151","author":"Yang","year":"2020","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.004_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.004_bib10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1210\/jcem-71-4-958","article-title":"An abnormality of the growth hormone\/insulin-like growth factor-I axis in women with polycystic ovary syndrome","volume":"71","author":"Kazer","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.004_bib11","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.fertnstert.2004.10.057","article-title":"Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome","volume":"83","author":"Premoli","year":"2005","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3906\/sag-1303-80","article-title":"Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism","volume":"44","author":"Cakir","year":"2014","journal-title":"Turk J Med Sci"},{"issue":"10","key":"10.1016\/j.eprac.2022.12.004_bib13","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.004_bib14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00404-014-3353-y","article-title":"Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance","volume":"290","author":"Kebapcilar","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.004_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0015-0282(99)00634-2","article-title":"Androgen excess contributes to altered growth hormone\/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome","volume":"73","author":"Wu","year":"2000","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.eprac.2022.12.004_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/humrep\/14.2.307","article-title":"The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome","volume":"14","author":"Carmina","year":"1999","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/eje.0.1440509","article-title":"Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome","volume":"144","author":"Kowalska","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09513590802056995","article-title":"Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1","volume":"24","author":"Liu","year":"2008","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2022.12.004_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000181561","article-title":"Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome","volume":"33","author":"Iwashita","year":"1990","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.004_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2265.1995.tb02691.x","article-title":"Dysfunction of the growth hormone\/insulin-like growth factor-I axis in women with polycystic ovarian syndrome","volume":"42","author":"Piaditis","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.004_bib21","first-page":"96","article-title":"Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters","volume":"36","author":"Atamer","year":"2008","journal-title":"J\u00a0Int Med Res"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.004_bib22","first-page":"1432","article-title":"An abnormality of the growth hormone\/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity","volume":"74","author":"Slowinska-Srzednicka","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0015-0282(16)54295-2","article-title":"Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease","volume":"55","author":"Suikkari","year":"1991","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.004_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0015-0282(16)57475-5","article-title":"Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome","volume":"63","author":"Morris","year":"1995","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.004_bib25","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/humrep\/14.11.2704","article-title":"Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome","volume":"14","author":"Kaltsas","year":"1999","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0026-0495(97)90191-8","article-title":"Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients","volume":"46","author":"Villa","year":"1997","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.004_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/humrep\/13.1.22","article-title":"Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome","volume":"13","author":"Kaltsas","year":"1998","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/09513599709152553","article-title":"Effect of growth hormone suppression on the serum levels of ovarian and adrenal sex steroid hormones in normal women and in women with polycystic ovary syndrome","volume":"11","author":"Takeuchi","year":"1997","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.eprac.2022.12.004_bib29","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.004_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eprac.2022.12.004_bib31","series-title":"Polycystic Ovary Syndrome","first-page":"39","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.004_bib32","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2022.12.004_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.eprac.2022.12.004_bib34","article-title":"Risk of dementia or cognitive impairment in COPD patients: a meta-analysis of cohort studies","volume":"14","author":"Wang","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"16","key":"10.1016\/j.eprac.2022.12.004_bib35","doi-asserted-by":"crossref","first-page":"e1620","DOI":"10.1212\/WNL.0000000000012701","article-title":"Subjective sleep quality and sleep architecture in patients with migraine: a meta-analysis","volume":"97","author":"Stanyer","year":"2021","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.004_bib36","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1007\/s43032-021-00709-w","article-title":"Blood circulating levels of adipokines in polycystic ovary syndrome patients: a systematic review and meta-analysis","volume":"28","author":"Mehrabani","year":"2021","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.004_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/humupd\/dmq027","article-title":"Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis","volume":"17","author":"Kelly","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"12","key":"10.1016\/j.eprac.2022.12.004_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.annepidem.2009.08.005","article-title":"Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race\/ethnicity and gender","volume":"19","author":"Faupel-Badger","year":"2009","journal-title":"Ann Epidemiol"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-0033-1348895","article-title":"Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome","volume":"31","author":"Wang","year":"2013","journal-title":"Semin Reprod Med"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.eprac.2022.12.004_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijgo.2009.09.021","article-title":"Association of biochemical\u00a0hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome","volume":"108","author":"Zhao","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.eprac.2022.12.004_bib42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","article-title":"Ethnic differences in the phenotypic expression of polycystic ovary syndrome","volume":"78","author":"Zhao","year":"2013","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.004_bib43","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/oby.2010.211","article-title":"Relationships between IGF-1 and IGFBP-1 and adiposity in obese African-American and Latino adolescents","volume":"19","author":"Alderete","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"10.1016\/j.eprac.2022.12.004_bib44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/clinchem\/33.7.1126","article-title":"Time-resolved immunofluorometric assay of 34-kDa somatomedin-binding protein","volume":"33","author":"Koistinen","year":"1987","journal-title":"Clin Chem"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:13Z","timestamp":1761516853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22008795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1530891X22008795"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.12.004","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Insulin-Like Growth Factor-1 With Polycystic Ovarian Syndrome: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}